The two companies signed a corresponding transfer agreement. Takeda will transfer the 24-hectare site, including buildings, infrastructure and some pharmaceutical production facilities, to Infrareal. The agreement is subject to customary legal and regulatory pre closing conditions including merger control approval in Austria. “Over the last 40 years and more, Orth an der Donau has developed […]
continue reading